Background/Aims: Tumor vascular formation and maintenance are crucial events in glioblastoma development. Mesenchymal stem cells (MSCs) have been shown to differentiate into pericytes and contribute to neovascularization in the glioma microenvironment. Moreover, glioblastoma-derived mesenchymal stem cells (gb-MSCs), which consist of CD90 -MSCs and CD90 + MSCs, are a subpopulation of MSCs that are more active in glioma vascularization. However, the functions of gb-MSCs and the microRNA (miRNA) modifications in the glioblastoma microenvironment have not yet been fully elucidated. Here, we focus on the pericyte differentiation potential of gb-MSCs and miRNA modifications in gb-MSCs during new vascular formation and glioblastoma growth. Methods: In vitro, surface markers of gbMSCs were detected by flow cytometry; the differentiation potential was evaluated by Oil Red O staining, Alizarin Red staining and Alcian blue staining; the proliferation and migration of gb-MSCs in different conditioned media were analyzed by the cck8 test and wound-healing assay, respectively; gb-MSC to pericyte transition was detected by immunofluorescence staining and western blot assay; angiogenetic capacity was analyzed by tube formation assay; and levels of cytokines in different supernatant were determined by ELISA. Additionally, RNA was isolated from gb-MSCs, and miRNA modifications were analyzed using the RAffymetrix miRNA microarray. Results: We showed that glioblastoma-conditioned medium increased gb-MSC proliferation and migration and was capable of inducing gb-MSC differentiation into pericytes. Glioblastoma secreted angiogenic factors and gb-MSCs incubated in malignant glioblastoma-conditioned medium formed more tube-like structures, and these cells also adhered to tube-like vessels formed by human umbilical vein endothelial cells (HUVECs) on Matrigel to maintain tumor vascular structure in vitro. miRNA expression were also modified in gb-MSCs cultured in malignant glioblastoma-conditioned medium in vitro. Conclusion: These results provide new insight into the functional effects of a subpopulation of MSCs in glioblastoma and may help in the development of novel therapies for solid tumors.
Introduction
Glioblastomas (GBMs) are the most common tumors and have a high mortality rate; GBMs are highly vascularized, and the extent of angiogenesis is significantly correlated with its prognosis [1] . Neovascular development supports tumor growth and invasion by providing oxygen and nutrients [2, 3] . Although new surgical techniques, radiotherapy and chemotherapy have been widely used to treat glioblastomas and have shown a striking effect, the prognosis of GBM tumors is still extremely poor [4, 5] . Recently, anti-vascular therapy has become a mainstream and promising therapeutic strategy for gliomas [1] .
Angiogenesis and vascular reconstruction are complex events that involve many pathways; the tumor vasculature consists of endothelial cells (ECs) and pericytes [6] [7] [8] [9] . Tumor vessels with poor pericyte coverage are more vulnerable to radiotherapy and chemotherapy, suggesting that pericytes protect ECs from therapy-induced apoptosis [10, 11] . Although, therapies targeting ECs have achieved some therapeutic effects, the prognosis is still poor, and anti-EC therapies may induce tumors to become a more invasive tumor type [12] . It is implied that the targeting of ECs alone is not sufficient for effective tumor control. Therefore, further insights into the role of pericytes in angiogenesis and tumor maintenance may improve the prognosis of glioblastoma patients.
Pericytes are closely associated with ECs and play a crucial role in vascular maturation, sprouting, stabilization and supporting vascular function [13] . However, pericytes on tumor vessels are irregularly shaped and loosely attached to ECs [14, 15] . During new vascular formation and remodeling, mesenchymal stem cells (MSCs) differentiate into pericytes and then migrate to cover the newly formed vasculature [16] . Accumulated studies have revealed that MSC to pericytes differentiation and attachment to endothelial is induced through several factors and its signaling networks including PDGF-β and VEGF [17, 18] .
MSCs are multipotent cells that express CD73, CD105, CD44 and CD90 and have the potential to differentiate into osteocytes, chondrocytes and adipocytes; it has been shown that the markers of MSCs are variable and greatly depend on not only the tissue in which they reside but also the microenvironment [19] [20] [21] [22] . Several studies have demonstrated that MSCs can be recruited to gliomas and transform into pericytes to promote tumor angiogenesis [23, 24] . These reports may be controversial due to the different expression of CD90 between glioblastoma-derived MSCs and bone marrow-derived mesenchymal stem cells (bm-MSCs). Resent study has demonstrated that gb-MSCs are partially differentiated from glioma stem cells [25] . Additionally, gb-MSCs have been shown to be a new subgroup of MSCs and be more active in glioma angiogenesis than bm-MSCs [26] . Meanwhile, the genomic sequence of CD90 -MSCs is different from that of bone marrow-derived CD90 + MSCs [26] . These findings suggest that native gb-MSCs may play a more important role in neovascularization than bm-MSCs, including vascular stabilization and contribution to the malignancy of gliomas. However, the role of gb-MSC differentiation, angiogenesis and attachment in glioblastoma and the phenotype, function and microRNA (miRNA) modifications of gb-MSCs within the tumor mass are still poorly understood. This missing information is essential for improving the understanding of gb-MSC-induced neovascularization and maintenance in tumors as well as for increasing the efficacy of anti-vascular therapies.
Therefore, we investigated the potential of glioblastoma-conditioned medium to enhance the proliferation and migration of gb-MSCs and differentiate gb-MSCs into pericytes and determined the significance of gb-MSC-derived pericytes in the maintenance of functional vessels to support glioblastoma growth. Moreover, we investigated the glioblastomaconditioned medium-induced miRNA modifications in gb-MSCs. The results showed that glioblastoma-conditioned medium is capable of increasing the proliferation and migration of gb-MSCs and differentiating gb-MSCs into pericytes; This study also demonstrates that glioblastoma-conditioned medium-induced pericytes are able to promote angiogenesis and stabilize vascular structures; In addition, this study reports the miRNA modifications induced by glioblastoma-conditioned medium.
Materials and Methods

Cell lines and Isolation of gb-MSCs and bm-MSCs
U87-MGs were purchased from the American Type Culture Collection (ATCC, Gaithersburg, MD, USA), and human umbilical vein endothelial cells (HUVECs) were purchased from Lonza, MD. U87-MGs and HUVECs were, respectively, kept in Dulbecco's modified Eagle's medium (DMEM) and RPMI1640 (both from HyClone, USA) supplemented with 10% fetal bovine serum (FBS; BI, Israel), 100 µ/ml Penicillin and 100 µ/ml Streptomycin in a 37°C incubator containing 5% CO 2 humidified atmosphere.
Gb-MSCs were obtained from tumor specimens from glioblastoma patients (WHO grade III and IV) who were provided informed consent. A pathological diagnosis was made based on the WHO criteria. Tumor specimens were freshly collected from the operation theater, transferred into phosphate-buffered saline (PBS) and processed within 1 h. Tumor specimens were washed in PBS and cut into 1-2-mm pieces. Collagenase (BIYUNTIAN, China) was added to the tumor specimens. Then, the individual specimens were digested for 30 min, passed through a 30-µm nylon mesh (Pall, USA) and then centrifuged at 1, 500 rpm for 15 min. The mononuclear cells were collected by Ficoll (2:1 Genview, USA) density gradient centrifugation at 1, 500 rpm for 20 min without braking. The cells were washed with PBS three times and then kept in DMEM (HyClone, USA) with 10% fetal bovine serum (BI, Israel), 100 µ/ml penicillin and 100 µ/ml streptomycin in a humidified atmosphere at 37°C containing 5% CO 2 .
Bone-marrow-MSC were obtained from residual material of fracture patients. Each of the patients who were provided informed consent. Then, the individual specimens were digested for 30 min, passed through a 30-µm nylon mesh (Pall, USA) and then centrifuged at 1, 500 rpm for 15 min. The mononuclear cells were collected by Ficoll (2:1 Genview, USA) density gradient centrifugation at 1, 500 rpm for 20 min without braking. The cells were washed with PBS three times and then kept in DMEM (HyClone, USA) with 10% fetal bovine serum (BI, Israel), 100 µ/ml penicillin and 100 µ/ml streptomycin in a humidified atmosphere at 37°C containing 5% CO 2 .
Differentiation
Cells were adipogenically, osteogenically and chondrogenically induced using ready-to-use differentiation media (all from Stemcell, Canada) following the manufacturer's instructions. Adipogenic differentiation was evaluated by Oil Red O staining, osteogenic differentiation was evaluated by Alizarin Red staining and chondrogenic differentiation was evaluated by Alcian Blue staining (all from Sigma).
Preparation of glioblastoma-conditioned medium U87 cells were kept in DMEM (HyClone, USA) supplemented with 10% FBS and passaged into serum-free medium (0% DMEM) and standard medium (10% DMEM, DMEM supplemented with 10% FBS). Then, the cells were grown for 72 h, and the culture supernatant was collected and centrifuged at 1, 000 g for 10 min to remove cells and cellular debris. Afterward, the collected glioblastoma conditioned media (0% gb-CM and S-gb-CM) were stored at -20°C for the experiments.
Flow cytometry
Flow cytometry analysis was performed using fluorochrome-conjugated antibodies. Briefly, subconfluent gb-MSCs were cultured in flasks with serum-free medium (0% DMEM), standard medium containing 10% FBS (10% DMEM), serum-free glioblastoma-conditioned medium (0% gb-CM) and standard glioblastoma-conditioned medium(s-gb-CM) for 72 h. The cells were trypsinized and collected in PBS. After centrifugation, the resuspended cells were stained with fluorochrome-conjugated antibodies, including anti-CD31-PE/Cy7, anti-CD34-FITC, anti-CD73-APC/Cy7, anti-CD90-PE/Cy7, anti-CD14-percp, anti-CD105-APC and anti-CD44-APC/Cy7 (all from ebioscience. USA) as well as anti-PDGFR-β-PE (R&D, USA) in the dark at 4°C for 30 min. Then, the cells were centrifuged, resuspended in PBS and analyzed using a FACS flow cytometer (BD Biosciences). The data were collected and analyzed using FlowJo (TreeStar, Ashland, OR) software.
CCK8 assay
Gb-MSCs were seeded onto a 96-well plate (1 × 10 5 cells/ml) and cultured overnight. Then, the medium was replaced with serum-free medium (0% DMEM), standard medium (10% DMEM), serum-free glioblastoma-conditioned medium (0% gb-CM) and standard glioblastoma-conditioned medium (S-gb-CM) Cellular Physiology and Biochemistry
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and cultured for 24, 48 and 72 hours. A 10-μl volume of CCK8 (Dojindo Laboratories, Japan) was added to each plate and incubated for 2 h at 37°C. Cell viability was measured by measuring the absorbance in the medium at 450 nm.
Wound-healing assay
A wound-healing assay was used to determine the gb-MSC migration ability in different media. GbMSCs were incubated in 6-well plates until 90% confluence. Then, cross lines were made using a 100-µl pipette tip and the debris was washed away with PBS. Then, the medium was replaced with standard medium (10% DMEM), serum-free medium (0% DMEM) serum-free glioblastoma-conditioned medium (0% gb-CM) or standard glioblastoma-conditioned medium (S-gb-CM). The width of the scratch wounds was photographed with an Olympus microscope at 0 and 24 hours. The assays were performed in triplicate at least three times, and data were analyzed using Image-Pro Plus.
Immunofluorescence Gb-MSCs and bm-MSCs were grown on an eight-well chamber slide (Ibidi, Germany) until 70% confluent and washed with PBS three times. Then, the medium was replaced with serum-free medium (0% DMEM) and serum-free glioblastoma-conditioned medium (0% gb-CM), and the cells were incubated for 72 hours at 37°C. The cells were fixed with 4% paraformaldehyde, permeabilized with Triton-X-100 and blocked with solution containing donkey serum (Antgene, WuHan; China) for 1 h at room temperature. Then, the cells were incubated with primary antibodies against α-SMA, Desmin (RD, USA), NG2, Nestin, CD31, CD151, VE-cadherin (VE-cad) or smooth muscle myosin (SMM) (Abcam, USA) overnight at 4°C. After being washed with PBS, the cells were incubated with secondary antibodies labeled with either fluorescein or rhodamine (Antgene, WuHan; China) for 1 h at room temperature. In each experiment, nonspecific staining by secondary antibodies was excluded by incubating a well without primary antibodies. The staining was visualized using 4', 6-diamidino-2-phenylindole (DAPI) (Antgene, WuHan; China). A digital image was acquired using an Olympus (Olympus, Japan) camera, and the results were analyzed using Image-Pro Plus.
Western blot assay
Gb-MSCs were cultured in standard medium (10% DMEM), serum-free medium (0% DMEM), serumfree glioblastoma-conditioned medium (0% gb-CM) or standard glioblastoma-conditioned medium (S-gb-CM) for 72 h. Cell lysates were obtained by treating the cells with lysis buffer followed by centrifugation at 4°C. Equal amounts of protein (40 μg) were subjected to SDS-PAGE and blotted onto a nitrocellulose membrane. Membranes were incubated overnight with primary antibodies against α-SMA and Desmin (both from R&D, USA) and then incubated with the appropriate secondary antibodies for 2 hours at room temperature. Protein bands were detected with X-ray film and analyzed.
Tube formation assay
Growth factor-reduced Matrigel (BD, USA) was added to a μ-Slide Angiogenesis (Ibidi, Germany) and polymerized at 37°C in 5% CO 2 for 40 min. Gb-MSCs were labeled using a DiO labeling kit (Yeasen, Shanghai, China). Labeled gb-MSCs and HUVECs were seeded (1 × 10 4 gb-MSCs/chamber, 1 × 10 4 HUVECs/chamber) or co-seeded (5 × 10 3 gb-MSCs/chamber, 1×10 4 HUVECs/chamber) into chambers containing 0% DMEM, 10% DMEM, 0% gb-CM or S-gb-CM. The µ-Slides were then incubated at 37°C in 5% CO 2 and photodocumented at 7 and 24 h. Capillary-like tube formation and the attachment of gb-MSCs on HUVECs were analyzed using ImageJ software (NIH, USA).
Elisa assay
The levels of VEGF, PDGF-β, FGF2 and TGF-β, in the supernatant of the each medium (0% DMEM, 10% DMEM, 0% gb-CM and S-gb-CM) exposed cells were determined by the ELISA kit (Neobioscience, China). The reaction was carried out according to the kit instructions. The reaction product was measured at 450 nm wavelength and the OD values were measured, the expression was analyzed.
RNA extraction and RAffymetrix miRNA microarray
Subconfluent gb-MSCs were incubated in serum-free medium (0% DMEM) and serum-free glioblastomaconditioned medium (0% gb-CM) for 72 h. Total RNA was isolated from gb-MSCs using TRIzol Reagent (Invitrogen, USA). After assessing RNA quality using a Nanodrop (Thomas Fisher Scientific), micrograms of total RNA from three gb-MSC samples cultured in 0% DMEM and three gb-MSC samples cultured in 0% gb-CM were labeled using the FlashTag Biotin HSR RNA Labeling Kit. Labeled total RNA was hybridized on
Results
Characterization of gb-MSCs
Gb-MSCs and bm-MSCs exhibited a spindle-shaped fibroblast-like appearance. The cells were adherent to flasks and grown in standard medium (Fig. 1B-1C) . Flow-cytometric analysis showed that the gb-MSCs exposed in 0% DMEM, 10% DMEM, 0% gb-CM and s-gb-CM expressed CD105, CD44, CD73 and CD90 but not CD 34, CD31, CD14 and PDGFR-β. Proportion of CD73
+ cell was significantly increased and CD90 + cells was slightly increased by cells cultured in gb-CM (0% gb-CM and s-gb-CM) (Fig. 1A) . In vitro, the ability of gb-MSCs to differentiate into adipocytes, osteoblasts and chondrocytes was tested by applying specific stimuli to promote adipogenesis, osteogenesis or chondrogenesis. Adipogenic differentiation was observed with Oil Red O staining, osteogenic differentiation was observed with Alizarin Red staining and chondrogenic differentiation was observed with Alcian blue staining (Fig. 1D-1F ). Gb-MSCs were shown to be able to differentiate into adipocytes, osteoblast and chondrocytes.
Cell proliferation and migration in different media
To demonstrate whether factors in glioblastoma-conditioned medium could enhance gb-MSC proliferation, the cells were incubated with 0% gb-CM, S-gb-CM, 0% DMEM or 10% DMEM and assessed by CCK8. We found that cell growth was significantly increased when cultured in glioblastoma-conditioned medium (0% gb-CM and S-gb-CM) compared to 0% DMEM and 10% DMEM (Fig. 2A) .
Cell migration was evaluated using the wound-healing assay, and we found that cells cultured in glioblastoma-conditioned medium (0% gb-CM and S-gb-CM) exhibited significantly greater migration ability than cells cultured in 0% DMEM or 10% DMEM. Cells cultured in S-gb-CM exhibited the greatest migration ability (Fig. 2B-2C ).
Gb-MSCs to pericytes transtion following incubation in glioblastoma-conditioned medium
It is well established that glioblastoma cells can closely communicate with the external environment and secrete different factors [23, 27] . It is also well-recognized that bm-MSCs can differentiate to pericytes by the stimulation of glioblastoma-conditioned medium [24] . However, whether and how gb-MSCs can differentiate to pericytes is still unclear. Therefore, we investigated whether exposure to glioblastoma cells can induce the differentiation of gb-MSCs to pericytes, and com- pared the morphological and biological parameters between gb-MSC and bm-MSC. To do so, 60% confluent gb-MSC and bm-MSC were incubated with 0% DMEM and 0% gb-CM for 72 h. immunofluorescent results showed that 0% DMEM-exposed gb-MSCs were slightly positive for α-SMA, Desmin, CD151 and VE-cadherin expression but negative for Nestin, Ng2, CD31 and SMM expression (Fig. 3A) . Gb-MSCs exposed to 0% gb-CM were strongly positive for α-SMA, Desmin, Ng2, CD151 and VEcadherin expression, slightly positive for Nestin expression, and negative for CD31 and SMM expression (Fig.  3B ). 0% DMEM exposed bm-MSC were slightly positive for α-SMA, Desmin and VE-cadherin expression but negative for Nestin, Ng2, CD151, CD31 and SMM expression. (Fig. 3C ) 0% gb-CM exposed bm-MSCs were strongly positive for Desmin and CD151 expression, slightly positive for α-SMA, Ng2 and VE-cadherin expression, and negative for Nestin, CD31 and SMM expression (Fig. 3D) . To confirm our immunofluorescent results, we performed double immunostaining and protein expression analyses on gb-MSCs cultured in 0% DMEM and 0% gb-CM and showed that not all cells expressed α-SMA and Desmin. Furthermore, the staining of α-SMA and Desmin were stronger in cells treated with 0% gb-CM for 72 h compared to those treated with 0% DMEM, and gb-MSCs cultured in gb-CM (0% gb-CM and S-gb-CM) exhibited significantly upregulated α-SMA and Desmin protein expression (Fig.  4A-4B ). 
Glioblastoma-conditioned medium can promote gb-MSC angiogenesis and enhance the stabilization of newly formed tubes
The involvement of pericytes and ECs in neovascularization is well established [13] . Therefore, we investigated whether incubating HUVECs and gb-MSCs in glioblastomaconditioned medium increases the formation of capillary structures. We found that tube formation at 7 h was significantly increased in cells incubated in gb-CM compared to those incubated in 0% DMEM and 10% DMEM (Fig. 5A-5B) .
Accordingly, number of tubes were significantly increased in cells incubated in 0% gb-CM and S-gb-CM compared to those in 0% DMEM and 10% DMEM (Fig. 5C ). Interestingly, gb-MSCs exposed to S-gb-CM formed thicker but fewer tubes compared to 0% gb-CMexposed gb-MSCs. Whereas, HUVECs exposed to S-gb-CM formed thickest tubes, but there was no significantly difference between the tube number in sgb-CM and 0% gb-CM.
The total tube segment lengths were also quantified, and the tube segment lengths of gb-MSCs and HUVECs incubated in 0% gb-CM and S-gb-CM were significantly longer than those in 0% DMEM and 10% DMEM (Fig. 5D) .
Furthermore, networks form by gb-MSC and HUVEC incubated in 0% gb-CM and S-gb-CM had more branching points compare to those in 0% DMEM and 10% DMEM. (Fig. 5E) .
To investigate the stability of the tubes formed by gb-MSCs in different media, gb-MSCs were seeded in µ-slides and incubated in 0% DMEM, 10% DMEM, 0% gb-CM or S-gb-CM. The tube networks were photographed at 7 and 24 hours and analyzed. The results showed that more tubes remained intact in the 0% gb-CM treated chambers than those in the 0% DMEM, but these were no significant difference between 0% gb-CM and S-gb-CM. (Fig. 5B, 5F ).
The attachment of pericytes to ECs help maintain and stabilize capillary-like structures [22] . Therefore, we sought to elucidate the effects of different media on the attachment of gb-MSC-derived pericytes. To do so, DiO-labeled gb-MSCs and HUVECs (1:2) were co-seeded in different media and photographed at 7 h when the tube networks were formed. Tube formation analyses showed that the attachment of gb-MSC-derived pericytes was significantly increased in gb-CM-treated chambers compared to those in 0% DMEM and 10% DMEM (Fig.  5G-5H ).
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Secretion of angiogenic factors in different condition medium
To analyze the secretion of angiogenic factors in different treatment medium, the supernatants were collected and assessed by ELISA. We found that the levels of VEGF and PDGF-β in the glioblastoma-conditioned medium (0% gb-CM and S-gb-CM) were significantly higher than those in 0% DMEM and 10% DMEM. (Fig. 6A-6B) The levels of FGF2 and TGF-β in S-gb-CM were significantly higher than those in 0% DMEM and 10% DMEM. However, the levels of FGF-2 in 0% gb-CM were higher than those in 0% DMEM, but these was no significantly deference between the levels of FGF2 in 0% gb-CM and 10% DMEM. (Fig. 6C-6D) The levels of TGF-β in 0% gb-CM were significantly higher than those in 0% DMEM but lower than those in 10% DMEM. (Fig. 6D) miRNA modifications in gb-MSCs induced by glioblastoma-conditioned medium miRNA analysis of cells cultured in different media (gb-MSCs cultured in 0% gb-CM and gbMSCs cultured in 0% DMEM) revealed that there was a different miRNA expression profile between cells cultured in 0% gb-CM and those cultured in 0% DMEM. A t test was subsequently performed to identify differentially expressed miRNA between cells cultured in 0% gb-CM and those cultured in 0% DMEM, and a total of 37 miRNA (19 upregulated and 18 downregulated in cells cultured in 0% gb-CM) were identified (Fig. 7A) . Differentially expressed miRNA target genes were predicted using Targetscan, microRNA.ORG and the miRDBA database, and the results The predicted target genes were enriched for vascular adhesion, cell differentiation and angiogenesis genes (Fig.7B) .
Collectively, these data demonstrate that gb-MSC differentiation into pericytes can be induced by glioblastoma-conditioned medium. Additionally, angiogenic ability was promoted and the stabilization of capillary-like structures was enhanced by exposure to glioblastomaconditioned medium.
Discussion
Bone marrow mesenchymal stem cells are capable of differentiating into pericytes and participating in angiogenesis during tumor formation; additionally, human malignant gliomas recruit bm-MSCs to the perivascular niche [18, 23, 24] . Although glioma-associated mesenchymal stem cells have been reported to be recruited from normal tissue [23] , the source of gb-MSCs is still controversial. Here, we investigate the potential of glioblastoma-conditioned medium to cause miRNA modifications in gb-MSCs and induce gb-MSC differentiation into pericytes that subsequently proliferate and migrate to maintain angiogenesis for tumor growth. We and others found that gb-MSCs [26, 28] in all treatment condition were positive for CD105, CD44, CD73 and 6 . Detection the Levels of VEGF, PDGF-β, FGF2 and TGF-β in different treatment medium by ELISA. A. VEGF (n ≥ 3) levels were significantly higher in gb-CM compare to those in 0% DMEM and 10% DMEM. B. PDGF-β (n ≥ 3) levels were significantly higher in gb-CM compare to those in 0% DMEM and 10% DMEM. C. FGF2 (n ≥ 3) levels were higher in gb-CM compare to those in 0% DMEM, and no significantly difference between 0% gb-CM and 10% DMEM. D. TGF-β (n ≥ 3) levels were significantly higher in S-gb-CM compare to those in 0% DMEM and 10% DMEM and 0% gb-CM, TGF-β levels in 0% gb-CM is higher than in 0% DMEM but lower than 10% DMEM. *P <0.05, **P<0.01, ***P<0.001 and ****P<0.0001.
CD90 but negative for CD31, CD 34 and CD14. Interestingly, bm-MSCs have been reported to highly express CD90 and PGDFR-β, malignant gb-MSCs lack CD90 expression [26, 29, 30] , whereas the gb-MSCs in our study not only lacked CD90 expression in most cells but also lacked PGDFR-β expression. Surprisingly, gb-CM (0% gb-CM and s-gb-CM) treated gb-MSCs showed increased expression of CD73 and CD90. CD73 have been reported to have ability of hydrolyzing AMP to produce adenosine, and the combination of adenosine and receptor can promote angiogenesis, and CD90 were also found to correlate with angiogenesis [31, 32] . Moreover, the proliferation, migration and attachment to ECs of gb-MSCs is necessary for angiogenesis. Our data suggest that glioblastoma-conditioned mediums are capable of enhancing gb-MSC proliferation and migration.
Furthermore, the immunofluorescent results showed that 0% gb-CM exposed gb-MSCs were strongly positive for pericyte marks of α-SMA, Desmin, Ng2, CD151 and VE-cadherin, and slightly positive for Nestin. Meanwhile, no SMM and CD31 expression was found on either 0% DMEM-exposed gb-MSCs or 0% gb-CM-exposed gb-MSCs. However, 0% gb-CM exposed bmMSCs were strongly positive for Desmin and CD151, and slightly positive for α-SMA, Ng2 and VE-cadherin expression. Moreover, no Nestin, SMM and CD31 expression were found on either 0% DMEM-exposed bm-MSCs or 0% gb-CM-exposed bm-MSCs. These results suggest that both gb-MSCs and bm-MSCs were able to differentiate into pericytes. Most interestingly, α-SMA, NG2 and VE-cadherin immunostaining signal in 0% gb-CM exposed gb-MSCs was higher compared to those in 0% gb-CM exposed bm-MSCs, gb-MSCs treated with 0% gb-CM were positive for Nestin expression but bm-MSCs treated with 0% gb-CM were negative, and gb-MSCs treated with 0% DMEM were positive for CD151 but bm-MSCs treated with 0% DMEM were negative. Meanwhile, recent studies have revealed that gb-MSCs were partially differentiated from glioma stem cell, and α-SMA + were more likely to support vascular structure but α-SMA -were more likely processed MSC-phenotype [25, 33] . Therefore, we hypothesized that bm-MSCs and gb-MSCs may different originated, and gb-MSCs can easier transformed into active sates of pericytes compare to bmMSCs.
Bone marrow-derived MSCs have been found to exhibit enhanced tube formation following induction with tumor-conditioned medium [18, 24] . In agreement with these findings, our in vitro tube formation assay showed that both gb-MSC and HUVEC angiogenesis was strongly stimulated by glioblastoma-conditioned medium. Tube segment length, the number of branching points and the number of tubes formed by gb-MSCs and HUVECs were enhanced in gb-CM compare to 0% DMEM and 10% DMEM. Moreover, 0% gb-CM-exposed gb-MSCs formed the most tubes. Additionally, we demonstrated that the percentage of retained gb-MSC-derived tubes at 24 h was higher in 0% gb-CM than in 0% DMEM. Thus, the study also suggest that glioblastomaconditioned medium increased the vascular stability in vitro.
The recruitment of pericytes onto blood vessels plays a key role in the termination of angiogenesis [6, 34] . Thus, we determined whether tumor cells are capable of increasing pericyte attachment to the newly formed endothelial vessels in vitro. We provided evidence that in addition to the induction of gb-MSC to pericyte transition, the glioblastoma-conditioned medium can also enhance the attachment of gb-MSC-derived pericytes onto newly formed vessels. We also observed the highest percentage of adherent gb-MSC-derived pericytes following treatment with gb-CM.
Previous studies demonstrate angiogenic factors such as VEGF, PDGF-β and TGF-β is relate to glioma angiogenesis [23, 27] , then were analyzed the levels of VEGF, PDGF-β, FGF2 and TGF-β in different treatment medium and found that levels of VEGF, PDGF-β, FGF2 and TGF-β in the gb-CM were significantly higher than those in 0% DMEM. Meanwhile, 10% DMEM performed lower VEGF, PDGF-β, TGF-β and FGF2 levels compared to S-gb-CM, lower VEGF and PDGF-β levels but higher TGF-β compared to 0% gb-CM. moreover, FGF2 in 10% DMEM performed no difference compared to those in 0% gb-CM. Therefore, we hypothesized that factors secreted by U87 cells may play a key role in gb-MSC to pericyte transition and angiogenesis of tumor. The correlation between the factors and gb-MSC to pericyte transition need to be further study.
To explore the miRNA modifications in gb-MSCs incubated in glioblastoma-conditioned medium, we analyzed the miRNA profile of gb-MSCs cultured either in 0% DMEM or 0% gb- [7, 35, 36] . In future studies, we will identify the specific miRNA and target gene pairs that are modified by glioblastomaconditioned medium to promote angiogenesis.
In conclusion, we successfully isolated gb-MSCs from primary human glioblastoma and described their expression profile. Our study also demonstrated gb-MSC to pericyte transition, showed that gb-MSC-derived pericytes were able to form vascular structure and adhere to ECs during the assembly of new blood vessels and analyzed the levels of angiogenic factors in different medium. Additionally, we provided evidence that glioblastomas can induce miRNA modifications in gb-MSCs that may affect tumor angiogenesis. These assays provide new insight into the role of the gb-MSC-like subpopulation in glioblastomas during angiogenesis. However, the mechanism underlying glioblastoma-induced miRNA modification and expression profile changes still requires additional research. Such studies may demonstrate a key role for the new subpopulation of MSCs in glioblastoma angiogenesis and support the use of gb-MSCs as a new vector in anti-angiogenic strategies for glioblastoma.
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